Replies to post #64639 on SOHM Inc (SHMN)

[drugmanrx]

Chart: I didn't forget them as they were pretty quiet during the Brainwise, the 14 new skus, distributor acquisition and the manufacturer acquisition Pr's that did not pan out as advertised.
And Aquilar was around for that out and out lie Gabapentin tweet and didn't correct it until I contacted him on LinkedIn.

SOHM is pleased to announce its newest private label Rx offering of Gabapentin Capsules. It is an anti-epileptic medication that is used to relieve the pain associated with neuropathic conditions. According to data, the US market for Gabapentin is approximately US $270 Mn. $SHMN pic.twitter.com/L8RfeBGyin

— SOHM, Inc. (@sohminc) May 10, 2022

Now with Aquilar COO and hopefully calling the shots SOHM future looks better then ever.

I hope you Aguilar, Bhatt & Dewey have a very informative chat.

[Mike2112]

Chart..

I agree with ur post 100%..

I have renewed confidence here because I think it is the new team pulling the strings....